Mitochondrial Complex I Deficiency via the NDUFV2 Gene
Summary and Pricing
Test Method
Exome Sequencing with CNV DetectionTest Code | Test Copy Genes | Test CPT Code | Gene CPT Codes Copy CPT Code | Base Price | |
---|---|---|---|---|---|
8431 | NDUFV2 | 81479 | 81479,81479 | $990 | Order Options and Pricing |
Pricing Comments
Our favored testing approach is exome based NextGen sequencing with CNV analysis. This will allow cost effective reflexing to PGxome or other exome based tests. However, if full gene Sanger sequencing is desired for STAT turnaround time, insurance, or other reasons, please see link below for Test Code, pricing, and turnaround time information.
An additional 25% charge will be applied to STAT orders. STAT orders are prioritized throughout the testing process.
Click here for costs to reflex to whole PGxome (if original test is on PGxome Sequencing platform).
Click here for costs to reflex to whole PGnome (if original test is on PGnome Sequencing platform).
The Sanger Sequencing method for this test is NY State approved.
For Sanger Sequencing click here.Turnaround Time
3 weeks on average for standard orders or 2 weeks on average for STAT orders.
Please note: Once the testing process begins, an Estimated Report Date (ERD) range will be displayed in the portal. This is the most accurate prediction of when your report will be complete and may differ from the average TAT published on our website. About 85% of our tests will be reported within or before the ERD range. We will notify you of significant delays or holds which will impact the ERD. Learn more about turnaround times here.
Targeted Testing
For ordering sequencing of targeted known variants, go to our Targeted Variants page.
Clinical Features and Genetics
Clinical Features
Mitochondrial complex I (CI) deficiency is characterized by a deficiency of the first and largest of the oxidative phosphorylation complexes (Fassone and Rahman 2012). Isolated mitochondrial CI deficiency is the most frequently reported childhood-onset mitochondrial disease, and may account for roughly one-third of all oxidative phosphorylation disorders (Skladal et al. 2003; Scaglia et al. 2004). Overproduction of lactic acid is a common finding in patients with this disorder.
NDUFV2-associated mitochondrial CI deficiency has been reported in only four families to date (Bénit et al. 2003; Pagniez-Mammeri et al. 2009; Cameron et al. 2015). In two families, affected individuals presented during infancy with seizures and Leigh Syndrome (LS) (Cameron et al. 2015). LS is a severe, progressive encephalopathy characterized by a distinct set of diagnostic criteria, which include psychomotor delay or regression; isolated or combined mitochondrial complex deficiencies; elevated levels of lactate in the blood and/or cerebral spinal fluid; bilateral symmetrical lesions in the brainstem and basal ganglia; and neurologic manifestations such as hypotonia or ataxia (Rahman and Thorburn 2015; Lake et al. 2015; Cameron et al. 2015). In the remaining two families, affected individuals presented with early-onset hypertrophic cardiomyopathy and encephalopathy (Bénit et al. 2003; Pagniez-Mammeri et al. 2009).
Genetics
The mitochondrial respiratory chain complex I (nicotinamide adenine dinucleotide (NADH):ubiquinone oxidoreductase) is composed of at least 45 structural subunits (Fassone and Rahman 2012). 38 of these subunits are encoded by nuclear DNA, and 7 are encoded by mitochondrial DNA. The resulting holoenzyme complex plays a critical role in redox-driven proton translocation, which ultimately results in synthesis of adenosine triphosphate (ATP; Sazanov 2015). Due to the many structural and accessory subunits required to support the assembly and function of complex I, mitochondrial CI deficiency is a genetically heterogeneous disorder. At least 33 genes have been shown to be involved in this disease to date (Fassone and Rahman 2012).
NDUFV2-associated mitochondrial complex I deficiency is inherited in an autosomal recessive pattern. The NDUFV2 gene encodes a structural subunit of the mitochondrial complex I flavoprotein fraction that is critical for catalytic function of the complex (de Coo et al. 1995). Only two causative variants, one small deletion and one small insertion, have been documented in this gene (Bénit et al. 2003; Cameron et al. 2015; Human Gene Mutation Database).
Clinical Sensitivity - Sequencing with CNV PGxome
At this time, due to the limited number of reported cases, the clinical sensitivity of NDUFV2-related mitochondrial complex I deficiency is difficult to estimate. The few reported pathogenic variants are detectable by sequencing.
Testing Strategy
This test provides full coverage of all coding exons of the NDUFV2 gene plus 10 bases of flanking noncoding DNA in all available transcripts along with other non-coding regions in which pathogenic variants have been identified at PreventionGenetics or reported elsewhere. We define full coverage as >20X NGS reads or Sanger sequencing. PGnome panels typically provide slightly increased coverage over the PGxome equivalent. PGnome sequencing panels have the added benefit of additional analysis and reporting of deep intronic regions (where applicable).
Dependent on the sequencing backbone selected for this testing, discounted reflex testing to any other similar backbone-based test is available (i.e., PGxome panel to whole PGxome; PGnome panel to whole PGnome).
Indications for Test
NDUFV2 sequencing should be considered for patients who present with symptoms consistent with mitochondrial complex I (CI) deficiency or for individuals with a family history of mitochondrial CI deficiency. We will also sequence the NDUFV2 gene to determine carrier status.
NDUFV2 sequencing should be considered for patients who present with symptoms consistent with mitochondrial complex I (CI) deficiency or for individuals with a family history of mitochondrial CI deficiency. We will also sequence the NDUFV2 gene to determine carrier status.
Gene
Official Gene Symbol | OMIM ID |
---|---|
NDUFV2 | 600532 |
Inheritance | Abbreviation |
---|---|
Autosomal Dominant | AD |
Autosomal Recessive | AR |
X-Linked | XL |
Mitochondrial | MT |
Disease
Name | Inheritance | OMIM ID |
---|---|---|
Mitochondrial Complex I Deficiency | AR | 252010 |
Related Tests
Citations
- Bénit P. et al. 2003. Human Mutation. 21:582-6. PubMed ID: 12754703
- Cameron J.M. et al. 2015. European Journal of Paediatric Neurology. 19:525-32. PubMed ID: 26008862
- de Coo R. et al. 1995. Genomics. 26:461-6. PubMed ID: 7607668
- Fassone and Rahman. 2012. PubMed ID: 22972949
- Human Gene Mutation Database (Bio-base).
- Lake N.J. et al. 2015. Journal of Neuropathy & Experimental Neurology. 74:482-92. PubMed ID: 25978847
- Pagniez-Mammeri H. et al. 2009. Molecular Genetics and Metabolism. 96:196-200. PubMed ID: 19167255
- Rahman S., Thorburn D. 2015. Nuclear Gene-Encoded Leigh Syndrome Overview. In: Pagon RA, Adam MP, Bird TD, Dolan CR, Fong C-T, Smith RJ, and Stephens K, editors. GeneReviews(®), Seattle (WA): University of Washington, Seattle. PubMed ID: 26425749
- Sazanov L.A. et al. 2015. Nature Reviews Molecular Cellular Biology. 16:375-88. PubMed ID: 25991374
- Scaglia et al. 2004. PubMed ID: 15466086
- Skladal et al. 2003. PubMed ID: 12805096
Ordering/Specimens
Ordering Options
We offer several options when ordering sequencing tests. For more information on these options, see our Ordering Instructions page. To view available options, click on the Order Options button within the test description.
myPrevent - Online Ordering
- The test can be added to your online orders in the Summary and Pricing section.
- Once the test has been added log in to myPrevent to fill out an online requisition form.
- PGnome sequencing panels can be ordered via the myPrevent portal only at this time.
Requisition Form
- A completed requisition form must accompany all specimens.
- Billing information along with specimen and shipping instructions are within the requisition form.
- All testing must be ordered by a qualified healthcare provider.
For Requisition Forms, visit our Forms page
If ordering a Duo or Trio test, the proband and all comparator samples are required to initiate testing. If we do not receive all required samples for the test ordered within 21 days, we will convert the order to the most effective testing strategy with the samples available. Prior authorization and/or billing in place may be impacted by a change in test code.
Specimen Types
Specimen Requirements and Shipping Details
PGxome (Exome) Sequencing Panel
PGnome (Genome) Sequencing Panel
ORDER OPTIONS
View Ordering Instructions1) Select Test Type
2) Select Additional Test Options
No Additional Test Options are available for this test.